Get the Stockscreener App
0.00
100.00%
-0.8441
Mainz Biomed N V stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
See More
Previous Close:
$0.8441
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$10.56M
Revenue:
$895.50K
Net Income/Loss:
$-26.30M
P/E Ratio:
0.00
EPS:
-65.5728
Net Cash Flow:
$-23.84M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$2.18
Mainz Biomed N V Stock (MYNZ) Company Profile
Name
Mainz Biomed N V
Sector
Industry
Phone
-
Address
-
Compare MYNZ vs TMO, DHR, IDXX, WAT, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MYNZ
Mainz Biomed N V
|
0.00 | 10.56M | 895.50K | -26.30M | -23.84M | -65.57 |
TMO
Thermo Fisher Scientific Inc
|
446.46 | 167.00B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
172.49 | 122.68B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
557.69 | 43.63B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
340.42 | 33.48B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
114.92 | 32.44B | 7.07B | 1.29B | 993.00M | 4.5355 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-25 | Initiated | Maxim Group | Buy |
| Nov-25-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-21-23 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-21-22 | Initiated | H.C. Wainwright | Buy |
Mainz Biomed N V Stock (MYNZ) Latest News
Guido Baechler files Form 144 to sell 200,000 MYNZ shares (MYNZ) - Stock Titan
Quantum Cyber (QUCY) director files Form 3 reporting zero ordinary shares - Stock Titan
Quantum Cyber (NASDAQ: MYNZ) director awarded 137,141 ordinary shares in Form 4 filing - Stock Titan
Quantum Cyber N.V. and Other Players Eye Potential CHIPS Act Funding From Trump Administration - TradingView
Quantum Cyber forms US defense subsidiary for drone programs - MSN
[144] Quantum Cyber N.V. SEC Filing - Stock Titan
Quantum Cyber (MYNZ) inks exclusive IP license with $5M cash and shares - Stock Titan
[10-Q] Quantum Cyber N.V. Quarterly Earnings Report - Stock Titan
Quantum Cyber site spotlights drones as Trump administration seeks $55B - Stock Titan
QUCY Stock Price, Quote & Chart | QUANTUM CYBER NV (NASDAQ:QUCY) - ChartMill
Quantum Cyber N.V. (QUCY-Q) Stock Price and News - The Globe and Mail
3 Penny Stocks to Watch Now, 5/14/26 - TipRanks
Quantum Cyber Stock Surges As Drone Deal And Ex-VA Chief Put Defense Pivot In Focus - TechStock²
Quantum Cyber appoints former VA acting secretary to board - Investing.com India
Mainz Biomed Stock Surges 315% as QUCY Hits $1.34 on Massive Volume - Meyka
Quantum Cyber N.V.Ordinary Shares (NQ: QUCY - FinancialContent
Quantum Cyber N.V. (QUCY) Stock: Drone Defense Deal Sparks 69% Rally - MEXC Exchange
Quantum Cyber N.V. (QUCY) Stock Soars 69% on BP United Drone Defense Partnership - MEXC Exchange
Cisco, Nokia, Ford, Quantum Cyber And Nebius Group: Why These 5 Stocks Are On Investors' Radars Today - Sahm
TradingKey - TradingKey
MSN Money - MSN
Quantum Cyber (MYNZ) boosts ATM share program to $100M, sets CFO consulting deal - Stock Titan
QUCY (Mainz) beats EPS estimates by 26% yet stock slides 3% despite cost discipline as revenue drops.Barrier to Entry - newser.com
Mainz Biomed changes ticker symbol to QUCY - MSN
QUCY Price History for Mainz Biomed N.V. Stock - Barchart
QUCYQuantum Cyber NV Stock Price and Quote - Finviz
Quantum Cyber N.V. completes major financing and governance overhaul - The Globe and Mail
Quantum Cyber N.V. Announces Name Change, Major Investment, and Board Restructuring Following Shareholder Approval - Minichart
Quantum Cyber N.V. (QUCY) director discloses 2,000 Ordinary Shares on Form 3 - Stock Titan
Quantum Cyber N.V. (QUCY) director files Form 3 showing zero share ownership - Stock Titan
CEO David Lazar expands Quantum Cyber N.V. (NASDAQ: MYNZ) preferred stake - Stock Titan
David Lazar secures control of Mainz Biomed (Nasdaq: MYNZ) with $6M deal - Stock Titan
Quantum Cyber (NASDAQ: MYNZ) outlines change of control and board overhaul - Stock Titan
What will be the closing price of QUCY stocks? - StockInvest.us
Mainz Biomed N.v. Stock Data and SignalsQUCY - StockInvest.us
QUCY Insider Trading (Mainz Biomed N.v. stock) - StockInvest.us
Mainz Biomed N.V. announced that it has received $6 million in funding - marketscreener.com
Mainz (QUCY) Stock Variable Dividend (Grinds Lower) 2026-04-20Shared Momentum Picks - newser.com
QUCY Should I Buy - Intellectia AI
Mainz Biomed Sells Next Gen Colorectal Cancer IP to Focus on Pancreatic Cancer and Post-Quantum Cybersecurity 7 - Minichart
Mainz Biomed NVenters asset purchase agreement on April 9, 2026 for next gen IP saleSEC filing - marketscreener.com
Mainz Biomed (NASDAQ: MYNZ) sells cancer IP and lifts equity above Nasdaq minimum - Stock Titan
An undisclosed buyer entered into a definitive agreement to acquire Next Gen IP of Mainz Biomed N.V. for ?1.2 million. - marketscreener.com
QUCY|Mainz Biomed N V Ord Shs|Price:0.502|Chg%:-0.04 - TradingKey
QUCY|Mainz Biomed N V Ord Shs|Price:0.380|Chg%:-0.01 - TradingKey
QUCY|Mainz Biomed N V Ord Shs|Price:0.380|Chg%:0.02 - TradingKey
QUCY|Mainz Biomed N V Ord Shs|Price:0.360|Chg%:-0.04 - TradingKey
Fundamentals Check: Is Mainz Biomed NV a defensive stockQuarterly Earnings Report & Proven Capital Preservation Methods - baoquankhu1.vn
Purchase/sale of business (net) of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Aug Retail: Whats the beta of Mainz Biomed NV stockTrade Performance Summary & Growth Focused Entry Reports - baoquankhu1.vn
Why Is Mainz Biomed N.V. (QUCY) Stock Up Today? - Meyka
Mainz Biomed N V Stock (MYNZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mainz Biomed N V Stock (MYNZ) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Donahue Kevin Michael | 10% Owner |
Oct 17 '25 |
Buy |
0.62 |
643,850 |
402,000 |
643,850 |
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):